Exelixis (EXEL) Amortization of Deferred Charges (2014 - 2017)

Exelixis (EXEL) recorded quarterly Amortization of Deferred Charges of $12.0 million in Q4 2017, up 476.43% quarter-over-quarter from $2.1 million in Q2 2017, and up 96.26% on a YoY basis from $6.1 million in Q4 2016.

Exelixis (EXEL) Amortization of Deferred Charges (2014 - 2017) Analysis & Trends

Exelixis' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $12.0 million for Q4 2017.

  • In Q4 2017, Amortization of Deferred Charges rose 96.26% year-over-year to $12.0 million; the TTM figure through Sep 2018 stood at $12.0 million (changed N/A YoY), while the FY2017 annual figure was $182000.0, down 97.73% from the prior year.
  • Amortization of Deferred Charges was $12.0 million for Q4 2017 at Exelixis, up from $2.1 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $22.3 million in Q4 2014 to a low of $89000.0 in Q1 2017.
  • Historically, Amortization of Deferred Charges has averaged $5.1 million across 4 years, with a median of $2.7 million in 2015.
  • Biggest YoY gain for Amortization of Deferred Charges was 1743.36% in 2017; the steepest drop was 97.18% in 2017.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $22.3 million in 2014, then slumped by 86.86% to $2.9 million in 2015, then soared by 108.88% to $6.1 million in 2016, then surged by 96.26% to $12.0 million in 2017.
  • The last three Amortization of Deferred Charges figures came in at $12.0 million (Q4 2017), $2.1 million (Q2 2017), and $89000.0 (Q1 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Dec 29, 2017 12.01 Mn
Dec 29, 2017 12.01 Mn
Jun 30, 2017 2.08 Mn
Jun 30, 2017 2.08 Mn
Mar 31, 2017 89,000.00
Mar 31, 2017 89,000.00
Dec 30, 2016 6.12 Mn
Dec 30, 2016 6.12 Mn
Sep 30, 2016 121,000.00
Sep 30, 2016 121,000.00
Jun 30, 2016 113,000.00
Jun 30, 2016 113,000.00
Mar 31, 2016 3.16 Mn
Mar 31, 2016 3.16 Mn
Sep 30, 2015 2.93 Mn
Sep 30, 2015 2.93 Mn
Jun 30, 2015 2.37 Mn
Jun 30, 2015 2.37 Mn
Dec 31, 2014 22.29 Mn
Dec 31, 2014 22.29 Mn